DarioHealth Corp. (DRIO) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
DRIO Revenue Growth
Revenue Breakdown (FY 2025)
DRIO's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
DRIO Revenue Analysis (2014–2025)
As of May 8, 2026, DarioHealth Corp. (DRIO) generated trailing twelve-month (TTM) revenue of $22.4 million, reflecting significant decline in growth of -31.2% year-over-year. The most recent quarter (Q4 2025) recorded $5.2 million in revenue, up 4.5% sequentially.
Looking at the longer-term picture, DRIO's 5-year compound annual growth rate (CAGR) stands at +24.2%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $27.7 million in 2022.
Revenue diversification analysis shows DRIO's business is primarily driven by Service (100%). With over half of revenue concentrated in Service, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including TDOC (-1.5% YoY), OMCL (+7.9% YoY), and NVCR (+8.5% YoY), DRIO has underperformed the peer group in terms of revenue growth. Compare DRIO vs TDOC →
DRIO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| DRIOCurrent | $22M | -31.2% | +24.2% | -163.9% | |
 TDOC | $2.5B | -1.5% | +18.3% | -10.4% | |
 OMCL | $1.2B | +7.9% | +5.8% | 0.4% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 HIMS | $2.3B | +59.0% | +73.6% | 5.2% | |
 DXCM | $4.7B | +16.2% | +19.3% | 19.6% |
DRIO Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $22.4M | -17.3% | $12.7M | 56.6% | $-36,655,000 | -163.9% |
| 2024 | $27.0M | +32.9% | $13.3M | 49.1% | $-57,744,000 | -213.6% |
| 2023 | $20.4M | -26.4% | $6.0M | 29.4% | $-56,189,000 | -276.1% |
| 2022 | $27.7M | +34.8% | $9.7M | 34.9% | $-56,810,000 | -205.4% |
| 2021 | $20.5M | +170.8% | $8.1M | 39.3% | $-76,494,000 | -372.9% |
| 2020 | $7.6M | +0.2% | $2.5M | 33.2% | $-29,903,000 | -394.7% |
| 2019 | $7.6M | +2.2% | $2.6M | 34.4% | $-17,705,000 | -234.2% |
| 2018 | $7.4M | +43.0% | $1.8M | 23.9% | $-17,688,000 | -239.2% |
| 2017 | $5.2M | +84.4% | $1.3M | 25.4% | $-14,419,000 | -278.9% |
| 2016 | $2.8M | +240.6% | $-561,000 | -20.0% | $-11,101,000 | -396.0% |
See DRIO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DRIO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DRIO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonDRIO — Frequently Asked Questions
Quick answers to the most common questions about buying DRIO stock.
Is DRIO's revenue growth accelerating or slowing?
DRIO revenue declined -31.2% year-over-year, contrasting with the 5-year CAGR of +24.2%. TTM revenue fell to $22M. This reverses the prior growth trend.
What is DRIO's long-term revenue growth rate?
DarioHealth Corp.'s 5-year revenue CAGR of +24.2% reflects the variable expansion pattern. Current YoY growth of -31.2% is below this long-term average.
How is DRIO's revenue distributed by segment?
DRIO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.